Laxmi will help people with diabetes stay in range more often thereby supporting better day-to-day control and long-term health.
Improve health outcomes by maximize Time in Range (TIR) through fast, dermal continuous glucose monitoring that's simple to use and built for everyday reliability.
Explore technology
Our comprehensive sensing solution includes a precision sensor, a transmitter, and an applicator designed to effectively reach the dermal tissue layer for accurate monitoring.
Show me how it works
Laxmi measures glucose in the dermis, a skin layer with strong vascular support and minimal adipose tissue. This enables glucose signals that track more closely with rapid changes thereby supporting faster awareness when it matters most.
Faster insight allows more precise insulin delivery during high rates of change, more confidence, and better decisions.
Rapid glucose changes are present during mealtimes, exercise, and hormonal changes (sickness & stress). Rapid changes are also regularly experienced by Type 1 diabetics while pregnant and pediatric Type 1 diabetics.
Every 10% reduction in TIR is associated with these increased risks of disease progression
Beck RW, et al. “The Relationship Between Time in Range and Complications in Type 1 Diabetes: Reanalysis of the DCCT Data.” Diabetes Care. 2019.
Our published research using the FDA-approved UVA/Padova Type I Diabetes Simulator (in silico model) demonstrates the proven link between TIR and the lag time of glucose measurements. Minimizing lag time increases TIR.
A small sensor wire is placed just under the skin, where it continuously measures the glucose level in the interstitial fluid.
The sensor wirelessly sends the measured glucose data (via Bluetooth) to a receiver device (a smartphone or dedicated reader).
The receiver displays the real-time glucose value, trend arrows (showing direction and speed of change), and enables the user to manage their treatment.
